{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T12:03:50Z","timestamp":1785153830447,"version":"3.55.0"},"reference-count":58,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Emer Care"],"published-print":{"date-parts":[[2016,7]]},"abstract":"<jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>The aim of the study was to evaluate the safety and efficacy of a standardized pediatric migraine practice guideline in the emergency department (ED).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Migraine Clinical Practice Guideline (MCPG) was created in collaboration with the Division of Pediatric Neurology and Pediatric Emergency Medicine. The MCPG was established on evidence-based data and best practice after a review of the literature. The MCPG was implemented for patients with a known diagnosis of migraine headaches and a verbal numeric pain score (VPS) greater than 6 on a 0 to 10 scale. Patients received intravenous saline, ketorolac, diphenhydramine, and either metoclopramide or prochlorperazine. After 40 minutes, another VPS was obtained, and if no improvement, a repeat dose of metoclopramide or prochlorperazine was administered. If after 40 minutes and minimal pain relief occurred, a consult to neurology was made. A chart review of patients enrolled in the MCPG from April 2004 to April 2013 was conducted. We recorded demographic data, vital signs, ED length of stay, initial VPS, last recorded VPS, adverse events, and admission rate. Nonparametric statistics were performed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 533 charts were identified with a discharge diagnosis of migraine headache of which 266 were enrolled in the MCPG (179 females and 87 males). Mean (SD) age was 13.9 (3.1). Mean (SD) initial VPS was 7.8 (2.0). Mean (SD) discharge VPS was 2.1 (2.8), representing a 73% reduction of pain. Twenty patients (7.5%) were admitted for status migrainosus; mean (SD) age was 14.0 (3.5) years and mean (SD) VPS was 6.3 (2.8). Mean (SD) length of stay in ED was 283 (107) minutes. No adverse events were identified.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Our MCPG was clinically safe and effective in treating children with acute migraine headaches. Our data add to the dearth of existing published literature on migraine treatment protocols in the ED setting. We recommend additional prospective and comparative studies to further evaluate the effectiveness of our protocol in this patient population.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/pec.0000000000000525","type":"journal-article","created":{"date-parts":[[2015,9,11]],"date-time":"2015-09-11T12:25:23Z","timestamp":1441974323000},"page":"435-439","source":"Crossref","is-referenced-by-count":21,"title":["The Use of a Pediatric Migraine Practice Guideline in an Emergency Department Setting"],"prefix":"10.1097","volume":"32","author":[{"given":"Courtney R.J.","family":"Kaar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Gerard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert K.","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"bib1-20231023","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1212\/WNL.48.1.103","article-title":"Ibuprofen or acetaminophen for the acute treatment of migraine in children: a double-blind, randomized, placebo-controlled, crossover study","volume":"48","year":"1997","journal-title":"Neurology"},{"key":"bib2-20231023","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1136\/bmj.309.6957.765","article-title":"Prevalence of headache and migraine in schoolchildren","volume":"309","year":"1994","journal-title":"BMJ"},{"key":"bib3-20231023","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1542\/pir.28.2.43","article-title":"Pediatric migraine","volume":"28","year":"2007","journal-title":"Pediatr Rev"},{"key":"bib4-20231023","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.pediatrneurol.2012.06.001","article-title":"Treatment of pediatric migraine in the emergency room","volume":"47","year":"2012","journal-title":"Pediatr Neurol"},{"key":"bib5-20231023","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0887-8994(03)00400-4","article-title":"Triptans for treatment of acute pediatric migraine: a systematic literature review","volume":"29","year":"2003","journal-title":"Pediatr Neurol"},{"key":"bib6-20231023","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1526-4610.1997.3705269.x","article-title":"Clinical and demographic characteristics of migraine in urban children","volume":"37","year":"1997","journal-title":"Headache"},{"key":"bib7-20231023","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1212\/WNL.0b013e318271f812","article-title":"Migraine and migraine subtypes in preadolescent children: association with school performance","volume":"79","year":"2012","journal-title":"Neurology"},{"key":"bib8-20231023","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/head.12042","article-title":"Effectiveness of standardized combination therapy for migraine treatment in the pediatric emergency department","volume":"53","year":"2013","journal-title":"Headache"},{"key":"bib9-20231023","doi-asserted-by":"crossref","first-page":"E62","DOI":"10.1542\/peds.107.4.e62","article-title":"Tolerability and effectiveness of prochlorperazine for intractable migraine in children","volume":"107","year":"2001","journal-title":"Pediatrics"},{"key":"bib10-20231023","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/MEJ.0b013e3283321162","article-title":"Practice variation after implementation of a protocol for migraines in children","volume":"17","year":"2010","journal-title":"Eur J Emerg Med"},{"key":"bib11-20231023","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jemermed.2008.08.012","article-title":"Clinical outcomes of children treated with intravenous prochlorperazine for migraine in a pediatric emergency department","volume":"39","year":"2010","journal-title":"J Emerg Med"},{"key":"bib12-20231023","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.1542\/peds.2009-2337","article-title":"Treatment of children with migraine in emergency departments: national practice variation study","volume":"126","year":"2010","journal-title":"Pediatrics"},{"key":"bib13-20231023","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/head.12255","article-title":"Chlorpromazine for the treatment of migraine in a pediatric emergency department","volume":"54","year":"2014","journal-title":"Headache"},{"key":"bib14-20231023","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/j.1526-4610.2007.00782.x","article-title":"Emergency department management of acute migraine in children in Canada: a practice variation study","volume":"47","year":"2007","journal-title":"Headache"},{"key":"bib15-20231023","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/PEC.0b013e31816ed047","article-title":"Treatment of children with migraine in the emergency department: a qualitative systematic review","volume":"24","year":"2008","journal-title":"Pediatr Emerg Care"},{"key":"bib16-20231023","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1097\/00007632-200012150-00009","article-title":"Assessing global pain severity by self-report in clinical and health services research","volume":"25","year":"2000","journal-title":"Spine (Phila Pa 1976)"},{"key":"bib17-20231023","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/00002508-200003000-00005","article-title":"A comparison of pain rating scales by sampling from clinical trial data","volume":"16","year":"2000","journal-title":"Clin J Pain"},{"key":"bib18-20231023","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.1365-2702.2005.01121.x","article-title":"Pain: a review of three commonly used pain rating scales","volume":"14","year":"2005","journal-title":"J Clin Nurs"},{"key":"bib19-20231023","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00002508-200407000-00002","article-title":"Pain intensity assessment in older adults: use of experimental pain to compare psychometric properties and usability of selected pain scales with younger adults","volume":"20","year":"2004","journal-title":"Clin J Pain"},{"key":"bib20-20231023","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1471-2288-5-31","article-title":"Lack of interchangeability between visual analogue and verbal rating pain scales: a cross sectional description of pain etiology groups","volume":"5","year":"2005","journal-title":"BMC Med Res Methodol"},{"key":"bib21-20231023","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0196-0644(03)00716-9","article-title":"Treatment of pediatric migraine headaches: a randomized, double-blind trial of prochlorperazine versus ketorolac","volume":"43","year":"2004","journal-title":"Ann Emerg Med"},{"key":"bib22-20231023","doi-asserted-by":"crossref","first-page":"e295","DOI":"10.1542\/peds.2004-2742","article-title":"Symptomatic treatment of migraine in children: a systematic review of medication trials","volume":"116","year":"2005","journal-title":"Pediatrics"},{"key":"bib23-20231023","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2165\/00023210-200620100-00003","article-title":"Migraine in children and adolescents: a guide to drug treatment","volume":"20","year":"2006","journal-title":"CNS Drugs"},{"issue":"suppl 2","key":"bib24-20231023","first-page":"S117","article-title":"Treatment strategies in the acute therapy of migraine: stratified care and early intervention","volume":"27","year":"2006","journal-title":"Neurol Sci"},{"key":"bib25-20231023","first-page":"316","article-title":"[Pharmacologic treatment of acute migraine attack in children]","volume":"12","year":"2005","journal-title":"Arch Pediatr"},{"key":"bib26-20231023","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1526-4610.2000.00004.x","article-title":"Headaches in a pediatric emergency department: etiology, imaging, and treatment","volume":"40","year":"2000","journal-title":"Headache"},{"key":"bib27-20231023","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1046\/j.1526-4610.2000.00029.x","article-title":"Acute headache in children and adolescents presenting to the emergency department","volume":"40","year":"2000","journal-title":"Headache"},{"key":"bib28-20231023","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1046\/j.1526-4610.2002.02180.x","article-title":"Children's ibuprofen suspension for the acute treatment of pediatric migraine","volume":"42","year":"2002","journal-title":"Headache"},{"key":"bib29-20231023","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1212\/01.wnl.0000231138.18629.d5","article-title":"Treatment of childhood migraine attacks with oral zolmitriptan and ibuprofen","volume":"67","year":"2006","journal-title":"Neurology"},{"key":"bib30-20231023","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1212\/WNL.48.4.1100","article-title":"Sumatriptan for migraine attacks in children: a randomized placebo-controlled study. Do children with migraine respond to oral sumatriptan differently from adults?","volume":"48","year":"1997","journal-title":"Neurology"},{"key":"bib31-20231023","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1046\/j.1526-4610.2002.02013.x","article-title":"Rizatriptan 5 mg for the acute treatment of migraine in adolescents: a randomized, double-blind, placebo-controlled study","volume":"42","year":"2002","journal-title":"Headache"},{"key":"bib32-20231023","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/j.1526-4610.2004.04171.x","article-title":"Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies","volume":"44","year":"2004","journal-title":"Headache"},{"key":"bib33-20231023","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1212\/01.wnl.0000238179.79888.44","article-title":"A randomized trial of rizatriptan in migraine attacks in children","volume":"67","year":"2006","journal-title":"Neurology"},{"key":"bib34-20231023","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1526-4610.2006.00313.x","article-title":"Zolmitriptan oral tablet in migraine treatment: high placebo responses in adolescents","volume":"46","year":"2006","journal-title":"Headache"},{"key":"bib35-20231023","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1212\/WNL.52.7.1507","article-title":"Intranasal sumatriptan for the acute treatment of migraine in children","volume":"52","year":"1999","journal-title":"Neurology"},{"key":"bib36-20231023","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1542\/peds.106.5.989","article-title":"A randomized, double-blind, placebo-controlled study of sumatriptan nasal spray in the treatment of acute migraine in adolescents","volume":"106","year":"2000","journal-title":"Pediatrics"},{"key":"bib37-20231023","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1212\/01.WNL.0000115105.05966.A7","article-title":"Nasal sumatriptan is effective in treatment of migraine attacks in children: A randomized trial","volume":"62","year":"2004","journal-title":"Neurology"},{"key":"bib38-20231023","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1526-4610.2006.00339.x","article-title":"Sumatriptan nasal spray in adolescent migraineurs: a randomized, double-blind, placebo-controlled, acute study","volume":"46","year":"2006","journal-title":"Headache"},{"key":"bib39-20231023","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1017\/S1481803500014718","article-title":"Myth: parenteral ketorolac provides more effective analgesia than oral ibuprofen","volume":"9","year":"2007","journal-title":"CJEM"},{"key":"bib40-20231023","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0196-0644(89)80570-0","article-title":"Comparative efficacy of chlorpromazine and meperidine with dimenhydrinate in migraine headache","volume":"18","year":"1989","journal-title":"Ann Emerg Med"},{"key":"bib41-20231023","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/emj.14.4.209","article-title":"Intravenous chlorpromazine versus intramuscular sumatriptan for acute migraine","volume":"14","year":"1997","journal-title":"J Accid Emerg Med"},{"key":"bib42-20231023","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0196-0644(05)81507-0","article-title":"A comparative trial of three agents in the treatment of acute migraine headache","volume":"19","year":"1990","journal-title":"Ann Emerg Med"},{"key":"bib43-20231023","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1136\/bmj.38281.595718.7C","article-title":"Parenteral metoclopramide for acute migraine: meta-analysis of randomised controlled trials","volume":"329","year":"2004","journal-title":"BMJ"},{"key":"bib44-20231023","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/S0196-0644(83)80251-0","article-title":"Parenteral chlorpromazine treatment of migraine","volume":"12","year":"1983","journal-title":"Ann Emerg Med"},{"key":"bib45-20231023","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1526-4610.2011.02070.x","article-title":"Rescue therapy for acute migraine, part 2: neuroleptics, antihistamines, and others","volume":"52","year":"2012","journal-title":"Headache"},{"key":"bib46-20231023","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ajem.2010.12.020","article-title":"Prochlorperazine in children with migraine: a look at its effectiveness and rate of akathisia","volume":"30","year":"2012","journal-title":"Am J Emerg Med"},{"key":"bib47-20231023","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1067\/mem.2001.113032","article-title":"Diphenhydramine for the prevention of akathisia induced by prochlorperazine: a randomized, controlled trial","volume":"37","year":"2001","journal-title":"Ann Emerg Med"},{"key":"bib48-20231023","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/emj.2010.094367","article-title":"Slow infusion metoclopramide does not affect the improvement rate of nausea while reducing akathisia and sedation incidence","volume":"29","year":"2012","journal-title":"Emerg Med J"},{"key":"bib49-20231023","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ajem.2008.03.044","article-title":"Slower infusion of metoclopramide decreases the rate of akathisia","volume":"27","year":"2009","journal-title":"Am J Emerg Med"},{"key":"bib50-20231023","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/pgmj.2007.057570","article-title":"Intravenous administration of metoclopramide by 2 min bolus vs 15 min infusion: does it affect the improvement of headache while reducing the side effects?","volume":"83","year":"2007","journal-title":"Postgrad Med J"},{"key":"bib51-20231023","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1136\/emj.2004.014712","article-title":"Rate of metoclopramide infusion affects the severity and incidence of akathisia","volume":"22","year":"2005","journal-title":"Emerg Med J"},{"key":"bib52-20231023","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0736-4679(00)00297-3","article-title":"Slow infusion for the prevention of akathisia induced by prochlorperazine: a randomized controlled trial","volume":"20","year":"2001","journal-title":"J Emerg Med"},{"key":"bib53-20231023","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0733-8619(05)70304-2","article-title":"Opioids in headache treatment. Is there a role?","volume":"15","year":"1997","journal-title":"Neurol Clin"},{"key":"bib54-20231023","doi-asserted-by":"crossref","first-page":"e1139","DOI":"10.1542\/peds.2013-3171","article-title":"National Patterns of Codeine Prescriptions for Children in the Emergency Department","volume":"133","year":"2014","journal-title":"Pediatrics"},{"key":"bib55-20231023","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1056\/NEJMoa041888","article-title":"Codeine intoxication associated with ultrarapid CYP2D6 metabolism","volume":"351","year":"2004","journal-title":"N Engl J Med"},{"key":"bib56-20231023","doi-asserted-by":"crossref","first-page":"11825","DOI":"10.1073\/pnas.90.24.11825","article-title":"Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine","volume":"90","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"bib57-20231023","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/S0140-6736(00)03167-6","article-title":"Pharmacogenetics and adverse drug reactions","volume":"356","year":"2000","journal-title":"Lancet"},{"key":"bib58-20231023","doi-asserted-by":"crossref","first-page":"e1343","DOI":"10.1542\/peds.2011-2538","article-title":"More codeine fatalities after tonsillectomy in North American children","volume":"129","year":"2012","journal-title":"Pediatrics"}],"container-title":["Pediatric Emergency Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006565-201607000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T02:03:47Z","timestamp":1698026627000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006565-201607000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":58,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/pec.0000000000000525","relation":{},"ISSN":["1535-1815","0749-5161"],"issn-type":[{"value":"1535-1815","type":"electronic"},{"value":"0749-5161","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]}}}